In all Organization for Economic Cooperation and Development (OECD) countries total spending on healthcare is rising faster than economic growth, pushing the average ratio of health spending to Gross Domestic Product (GDP) from 7.8% in 2000 to 9.0% in 2008. Factors pushing health spending up - technological change, population expectations and population ageing - will continue to drive cost higher in the future.
In some countries, according to the new report from the OECD Health Data 2010 report, the recent economic downturn, with GDP falling and health care costs rising, led to a sharp increase in the ratio of health spending to GDP. In Ireland, the percentage of GDP devoted to health increased from 7.5% in 2007 to 8.7% in 2008. In Spain, it rose from 8.4% to 9.0%.
The USA spent $7,538 per person on health in 2008, well over double the $3,000 average of all OECD countries. However, a separate study recently put the USA as having the worst health system, despite its higher spending (The Pharma Letter June 24). The next biggest spenders, Norway and Switzerland, spent much less than the USA per capita but still some 50% more than the OECD average.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze